Guangyao Jiang

1.4k total citations · 1 hit paper
48 papers, 1.1k citations indexed

About

Guangyao Jiang is a scholar working on Molecular Biology, Orthopedics and Sports Medicine and Oncology. According to data from OpenAlex, Guangyao Jiang has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Orthopedics and Sports Medicine and 12 papers in Oncology. Recurrent topics in Guangyao Jiang's work include Bone Metabolism and Diseases (16 papers), Bone health and treatments (10 papers) and Tendon Structure and Treatment (7 papers). Guangyao Jiang is often cited by papers focused on Bone Metabolism and Diseases (16 papers), Bone health and treatments (10 papers) and Tendon Structure and Treatment (7 papers). Guangyao Jiang collaborates with scholars based in China, Canada and United Kingdom. Guangyao Jiang's co-authors include Jianqiao Hong, Shigui Yan, Sihao Li, Jiahong Meng, Ruijian Yan, Gang Feng, Weishan Chen, Chenyi Ye, Zhongli Shi and Bin He and has published in prestigious journals such as ACS Nano, Advanced Functional Materials and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Guangyao Jiang

46 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A 3D-printed PRP-GelMA hydrogel promotes osteochondral regeneration through M2 macrophage polarization in a rabbit model

2021 197 citations Guangyao Jiang, Sihao Li et al. Acta Biomaterialia profile →

Peers

Guangyao Jiang

SURGE

OSM

Song Wu China

Jyh‐Horng Wang Taiwan

Pei Yang China

Yuefeng Hao China

Xing Yin China

Guolin Meng China

Chiyuan Ma China

Hongrui Liu China

Qiaoli Gu China

Rinaldo Florencio‐Silva Brazil

Song Wu China

Guangyao Jiang

547 ×1.3

222 ×1.1

SURGE

162 ×0.8

131 ×0.7

OSM

377 ×2.3

Citations per year, relative to Guangyao Jiang Guangyao Jiang (= 1×) peers Song Wu

Countries citing papers authored by Guangyao Jiang

Since Specialization

Citations

This map shows the geographic impact of Guangyao Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangyao Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangyao Jiang more than expected).

Fields of papers citing papers by Guangyao Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangyao Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangyao Jiang. The network helps show where Guangyao Jiang may publish in the future.

Co-authorship network of co-authors of Guangyao Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Guangyao Jiang. A scholar is included among the top collaborators of Guangyao Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangyao Jiang. Guangyao Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Guangyao, et al.. (2025). Comparative efficacy and safety of antidiabetic drugs for obese patients with knee osteoarthritis: a network meta-analysis of randomized controlled trials. Aging Clinical and Experimental Research. 37(1). 142–142. 1 indexed citations

Zheng, Tao, et al.. (2023). Pogostone attenuates osteolysis in breast cancer by inhibiting the NF-kB and JNK signaling pathways of osteoclast. Life Sciences. 328. 121611–121611. 5 indexed citations

Wu, Yifan, Kaihang Zhang, Sihao Li, et al.. (2023). Self-powered wearable electrical stimulation patch with integrated triboelectric nanogenerator for tendinopathy treatment. Nano Energy. 121. 109234–109234. 11 indexed citations

Lu, Jinwei, Yazhou Chen, Congsun Li, et al.. (2023). Rejuvenation of tendon stem/progenitor cells for functional tendon regeneration through platelet-derived exosomes loaded with recombinant Yap1. Acta Biomaterialia. 161. 80–99. 45 indexed citations

Jiang, Guangyao, Junjie Chen, Yan Li, et al.. (2023). Association of SMC4 with prognosis and immune infiltration of sarcoma. Aging. 15(2). 567–582. 4 indexed citations

Ji, Xiaoxiao, Jianqiao Hong, Jie Wang, et al.. (2023). GSTP1-mediated S-glutathionylation of Pik3r1 is a redox hub that inhibits osteoclastogenesis through regulating autophagic flux. Redox Biology. 61. 102635–102635. 10 indexed citations

Li, Congsun, Jie Wang, Kang Yu, et al.. (2023). 3D-printed hydrogel particles containing PRP laden with TDSCs promote tendon repair in a rat model of tendinopathy. Journal of Nanobiotechnology. 21(1). 177–177. 20 indexed citations

Zhang, Wenkan, Guangyao Jiang, Xiaozhong Zhou, et al.. (2022). α-Mangostin inhibits LPS-induced bone resorption by restricting osteoclastogenesis via NF-κB and MAPK signaling. Chinese Medicine. 17(1). 34–34. 14 indexed citations

Chen, Minghui, et al.. (2021). Stachydrine hydrochloride inhibits osteoclastogenesis by regulating the NF-κB and p38 signaling pathways to alleviate postmenopausal osteoporosis. Biochemical and Biophysical Research Communications. 542. 1–8. 7 indexed citations

10.

Hong, Jianqiao, Zhongli Shi, Congsun Li, et al.. (2021). Virtual screening identified natural Keap1-Nrf2 PPI inhibitor alleviates inflammatory osteoporosis through Nrf2-mir214-Traf3 axis. Free Radical Biology and Medicine. 171. 365–378. 13 indexed citations

11.

Jiang, Guangyao, Tingting Tan, Cheng Xiang, et al.. (2021). Punicalin Attenuates Breast Cancer-Associated Osteolysis by Inhibiting the NF-κB Signaling Pathway of Osteoclasts. Frontiers in Pharmacology. 12. 789552–789552. 10 indexed citations

12.

Jiang, Guangyao, Sihao Li, Kang Yu, et al.. (2021). A 3D-printed PRP-GelMA hydrogel promotes osteochondral regeneration through M2 macrophage polarization in a rabbit model. Acta Biomaterialia. 128. 150–162. 197 indexed citations breakdown →

13.

Ouyang, Zhengxiao, Tingting Tan, Xianghong Zhang, et al.. (2020). LncRNA ENST00000563492 promoting the osteogenesis–angiogenesis coupling process in bone mesenchymal stem cells (BMSCs) by functions as a ceRNA for miR-205-5p. Cell Death and Disease. 11(6). 486–486. 30 indexed citations

14.

Meng, Jiahong, Wenkan Zhang, Cong Wang, et al.. (2019). Catalpol suppresses osteoclastogenesis and attenuates osteoclast-derived bone resorption by modulating PTEN activity. Biochemical Pharmacology. 171. 113715–113715. 56 indexed citations

15.

Ye, Chenyi, Wei Zhang, Kai Hang, et al.. (2019). Extracellular IL-37 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells via activation of the PI3K/AKT signaling pathway. Cell Death and Disease. 10(10). 753–753. 69 indexed citations

16.

Meng, Jiahong, Chenhe Zhou, Bin Hu, et al.. (2018). Stevioside Prevents Wear Particle-Induced Osteolysis by Inhibiting Osteoclastogenesis and Inflammatory Response via the Suppression of TAK1 Activation. Frontiers in Pharmacology. 9. 1053–1053. 10 indexed citations

17.

Yang, Yute, Jiahong Meng, Bin Hu, et al.. (2018). A novel anti-osteoporotic agent that protects against postmenopausal bone loss by regulating bone formation and bone resorption. Life Sciences. 209. 409–419. 12 indexed citations

18.

Hong, Jianqiao, Yangxin Wang, Guangyao Jiang, et al.. (2018). Association between SMAD3 gene polymorphisms and osteoarthritis risk: a systematic review and meta-analysis. Journal of Orthopaedic Surgery and Research. 13(1). 232–232. 13 indexed citations

19.

Jiang, Guangyao, et al.. (2017). Which is the optimum surgical strategy for spondylolisthesis: Reduction or fusion in situ? A meta-analysis from 12 comparative studies. International Journal of Surgery. 42. 128–137. 7 indexed citations

20.

Zhao, Zhiwei, Yingbo Lin, Yali Miao, et al.. (2017). Epithelial-mesenchymal transition in cancer: Role of the IL-8/IL-8R axis. Oncology Letters. 13(6). 4577–4584. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact